Aastrom Biosciences


Maxim Group Maintains Cautious Stance On Aastrom Following 3Q14 Update

In a research report sent to investors today, Maxim Group analyst Jason Kolbert maintained a Hold rating on Aastrom Biosciences (NASDAQ:ASTM), following the …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts